Condition: HER2-positive Breast Cancer · Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
This is a randomized, open, positive drug control, multi center phase III study. Through the evaluation of tpCR, bpCR, ORR, EFS, IDFS, OS , AEs and other indicators, it proves the effectiveness and safety of TQB2102 for injection versus TCbHP in the neoadjuvant treatment of HER2 positive breast cancer patients.
This description comes directly from the study's public registry record.
Zhimin Shao, Doctor · 13524514617 · szm@163.com
Caigang Liu, Doctor · 18940256668 · zlzxlcsy@163.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Bengbu Medical University | Bengbu, Anhui, China | Not Yet Recruiting |
| Anhui Provincial Cancer Hospital | Hefei, Anhui, China | Not Yet Recruiting |
| The First Affiliated Hospital of Wannan Medical University | Wuhu, Anhui, China | Not Yet Recruiting |
| Peking Union Medical College Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Beijing Cancer Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| The Cancer Hospital Affiliated to Chongqing University, Chongqing Cancer Hospital, Chongqing Cancer Research Institute, and Chongqing Cancer Center | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| The First Hospital Affiliated to Army Medical University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| Quanzhou First Hospital | Quanzhou, Fujian, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Fujian Medical University | Quanzhou, Fujian, China | Not Yet Recruiting |
| Zhongshan Hospital Xiamen university | Xiamen, Fujian, China | Not Yet Recruiting |
+ 66 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07043725